Latest News & Features
Africa
Teva and Regeneron Pharmaceuticals have combined to develop and commercialise fasinumab, a novel nerve growth factor (NGF) antibody. 22 September 2016
Americas
Allergan has entered into an agreement to acquire Tobira Therapeutics for up to $1.7 billion. 22 September 2016
Americas
Sanofi has filed a complaint against Merck for allegedly infringing ten of its patents centring on the diabetes drugs Lantus and Lantus SoloSTAR. 21 September 2016
Europe
A decision by Germany’s Federal Court of Justice has developed the concept of the ‘doctrine of equivalents’, possibly benefiting pharma patent owners, say Bernd Allekotte and Markus Grammel of Grünecker. 20 September 2016
Americas
Pharmaceutical pay-for-delay deals worth less than around $10 million are unlikely to be challenged by the authorities in US courts, according to a speaker at the 2016 AIPPI World Congress in Milan. 20 September 2016
Biotechnology
In a session moderated by Dominic Adair of Bristows, panellists at the 2016 AIPPI World Congress in Milan yesterday discussed biosimilars substitution and interchangeability. 20 September 2016
Big Pharma
Sweden-based pharmaceutical research company BioInvent International has been granted additional patent protection for its BI-505 immune oncology programme for myeloma. 19 September 2016
Americas
A patent counsel at Eli Lilly has blasted the US Supreme Court for being lazy in its approach to assessing the patentability of gene-based sequencing. 19 September 2016
Big Pharma
Brexit does not mean Brexit—it means “total chaos”, said one IP lawyer speaking at the 2016 AIPPI World Congress in Milan today. 19 September 2016
Big Pharma
The Association of the British Pharmaceutical Industry has welcomed the Department of Health’s new £816 million investment in health research, stating that it is “a signal of the government’s commitment to invest in innovation”. 16 September 2016